ASCO: Clinical and QOL Benefits With Arimidex in Endometrial Ca (CME/CE)

(MedPage Today) -- 44% clinical benefit rate, median PFS of 3.2 months in recurrent disease
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news